Mechanism of Inhibition of Enveloped Virus Membrane Fusion by the Antiviral Drug Arbidol
2011

How Arbidol Stops Viruses from Entering Cells

publication 10 minutes Evidence: moderate

Author Information

Author(s): Teissier Elodie, Zandomeneghi Giorgia, Loquet Antoine, Lavillette Dimitri, Lavergne Jean-Pierre, Montserret Roland, Cosset François-Loïc, Böckmann Anja, Meier Beat H., Penin François, Pécheur Eve-Isabelle

Primary Institution: Institut de Biologie et Chimie des Protéines, UMR 5086, CNRS, Université de Lyon, IFR128 BioSciences Gerland-Lyon Sud, Lyon, France

Hypothesis

Can arbidol inhibit the entry and fusion of enveloped viruses with host cells?

Conclusion

Arbidol inhibits the entry and membrane fusion of hepatitis C virus by interacting with both lipid membranes and viral proteins.

Supporting Evidence

  • Arbidol interacts with phospholipids at the membrane interface.
  • Fluorescence studies show that arbidol binds to tryptophan residues in a micromolar range.
  • Arbidol inhibits HCV entry and membrane fusion in a genotype-independent manner.

Takeaway

Arbidol is a medicine that helps stop viruses from getting into our cells by sticking to the virus and the cell's outer layer.

Methodology

The study used various biochemical techniques including NMR, fluorescence spectroscopy, and surface plasmon resonance to analyze the interactions of arbidol with membranes and viral proteins.

Limitations

The study primarily focused on hepatitis C virus and may not generalize to all enveloped viruses.

Digital Object Identifier (DOI)

10.1371/journal.pone.0015874

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication